M Netzer1, G Millonig, M Osl, B Pfeifer, S Praun, J Villinger, W Vogel, C Baumgartner. 1. Research Group for Clinical Bioinformatics, Institute of Biomedical Engineering, University for Health Sciences, Medical Informatics and Technology (UMIT), Innsbruck Medical University, Innsbruck, Austria. michalel.netzer@umit.at
Abstract
MOTIVATION: Alcoholic fatty liver disease (AFLD) and non-AFLD (NAFLD) can progress to severe liver diseases such as steatohepatitis, cirrhosis and cancer. Thus, the detection of early liver disease is essential; however, minimal invasive diagnostic methods in clinical hepatology still lack specificity. RESULTS: Ion molecule reaction mass spectrometry (IMR-MS) was applied to a total of 126 human breath gas samples comprising 91 cases (AFLD, NAFLD and cirrhosis) and 35 healthy controls. A new feature selection modality termed Stacked Feature Ranking (SFR) was developed to identify potential liver disease marker candidates in breath gas samples, relying on the combination of different entropy- and correlation-based feature ranking methods including statistical hypothesis testing using a two-level architecture with a suggestion and a decision layer. We benchmarked SFR against four single feature selection methods, a wrapper and a recently described ensemble method, indicating a significantly higher discriminatory ability of up to 10-15% for the SFR selected gas compounds expressed by the area under the ROC curve (AUC) of 0.85-0.95. Using this approach, we were able to identify unexpected breath gas marker candidates in liver disease of high predictive value. A literature study further supports top-ranked markers to be associated with liver disease. We propose SFR as a powerful tool for biomarker search in breath gas and other biological samples using mass spectrometry. AVAILABILITY: The algorithm SFR and IMR-MS datasets are available under http://biomed.umit.at/page.cfm?pageid=526.
MOTIVATION:Alcoholic fatty liver disease (AFLD) and non-AFLD (NAFLD) can progress to severe liver diseases such as steatohepatitis, cirrhosis and cancer. Thus, the detection of early liver disease is essential; however, minimal invasive diagnostic methods in clinical hepatology still lack specificity. RESULTS: Ion molecule reaction mass spectrometry (IMR-MS) was applied to a total of 126 human breath gas samples comprising 91 cases (AFLD, NAFLD and cirrhosis) and 35 healthy controls. A new feature selection modality termed Stacked Feature Ranking (SFR) was developed to identify potential liver disease marker candidates in breath gas samples, relying on the combination of different entropy- and correlation-based feature ranking methods including statistical hypothesis testing using a two-level architecture with a suggestion and a decision layer. We benchmarked SFR against four single feature selection methods, a wrapper and a recently described ensemble method, indicating a significantly higher discriminatory ability of up to 10-15% for the SFR selected gas compounds expressed by the area under the ROC curve (AUC) of 0.85-0.95. Using this approach, we were able to identify unexpected breath gas marker candidates in liver disease of high predictive value. A literature study further supports top-ranked markers to be associated with liver disease. We propose SFR as a powerful tool for biomarker search in breath gas and other biological samples using mass spectrometry. AVAILABILITY: The algorithm SFR and IMR-MS datasets are available under http://biomed.umit.at/page.cfm?pageid=526.
Authors: Christian Baumgartner; Gregory D Lewis; Michael Netzer; Bernhard Pfeifer; Robert E Gerszten Journal: Bioinformatics Date: 2010-05-18 Impact factor: 6.937
Authors: M E Dolch; C Hornuss; C Klocke; S Praun; J Villinger; W Denzer; G Schelling; S Schubert Journal: Eur J Clin Microbiol Infect Dis Date: 2012-07-11 Impact factor: 3.267
Authors: Mahesh Visvanathan; Michael Netzer; Michael Seger; Bhargav S Adagarla; Christian Baumgartner; Sitta Sittampalam; Gerald H Lushington Journal: Int J Comput Biol Drug Des Date: 2009-12-10
Authors: Rosa A Sola Martínez; José M Pastor Hernández; Óscar Yanes Torrado; Manuel Cánovas Díaz; Teresa de Diego Puente; María Vinaixa Crevillent Journal: Pediatr Res Date: 2020-09-12 Impact factor: 3.756